189 results
Page 8 of 10
6-K
EX-99.1
4zy5vp45bq gz9ovcmb
2 May 18
RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO
12:01pm
20-F/A
bwwdzgj03wemw01bqe
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
fomhm iswil
25 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.2
a0i6rs rjn3e4mbe
13 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
11atk
13 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
wbbby
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.1
t4tv6j3ztbvvwf2x3bu
6 Apr 16
Replicel Life Sciences Announces Restructuring, Cost Reductions and Closing
12:00am
6-K
EX-99.1
c4qaq6 9bpjrajewqm3b
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
vzrm9gxe84d ha
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
4ip1kgkbch 6qgtil
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
6-K
EX-99.1
ulvhui8f
21 Jan 15
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
12:00am
6-K
EX-99.1
9y1h0l
7 Jan 15
RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco
12:00am
CORRESP
jksaq17f yh5q80
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
vvfmikdayfz8c3kdaeof
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
0f2bh
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.1
jv1ik oijimtm
26 Nov 14
RepliCel Announces 2014 Third Quarter Financial Results
12:00am
6-K
EX-99.1
ukgscnltmdsio51jw8fq
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am